These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7221526)

  • 1. [Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels].
    Brogard JM; Audhuy B; Spach MO
    Schweiz Med Wochenschr; 1981 Feb; 111(6):197-201. PubMed ID: 7221526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
    Brogard JM; Comte F; Madon M; Spach MO
    Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetic and metabolic studies.
    Nash JF; Carmichael RH; Ridolfo AS; Spradlin CT
    J Rheumatol Suppl; 1980; 6():12-9. PubMed ID: 6930483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of benoxaprofen in elderly subjects.
    Hamdy RC; Murnane B; Perera N; Woodcock K; Koch IM
    Eur J Rheumatol Inflamm; 1982; 5(2):69-75. PubMed ID: 7084284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and serum levels of benoxaprofen in healthy volunteers.
    Furlanut M; Montanari G; Colonna V; Perosa A
    Int J Clin Pharmacol Res; 1983; 3(3):163-6. PubMed ID: 6679519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cephacetrile--application of pharmacokinetic data to dosage determination.
    Brogard JM; Dorner M; Brandt C; Lavillaureix J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency.
    Nilsen OG; Wessel-Aas T; Walseth F
    Arzneimittelforschung; 1985; 35(5):871-5. PubMed ID: 4026912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renal function on recainam pharmacokinetics and pharmacodynamics.
    Cheng JW; Charland SL; Goldfarb S; Spinler SA
    Clin Pharmacol Ther; 1995 May; 57(5):492-8. PubMed ID: 7768071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study in man with the non-steroidal antiinflammatory drug flunoxaprofen. Serum concentration-time profile after oral or topical preparations.
    Bareggi SR; Pedrazzini S; De Angelis M
    Arzneimittelforschung; 1988 Apr; 38(4):574-7. PubMed ID: 3401272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies of benoxaprofen in geriatric patients.
    Kamal A; Koch IM
    Eur J Rheumatol Inflamm; 1982; 5(2):76-81. PubMed ID: 7084285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
    Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
    Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G; Leroy A; Godin M; Fillastre JP
    Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.